Vaishampayan UN - Search Results

1

Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.

Vaishampayan UN, Marur S, Heilbrun LK, Cher ML, Dickow B, Smith DW, Al Hasan SA, Eliason J. Vaishampayan UN, et al. J Urol. 2009 Jul;182(1):317-23. doi: 10.1016/j.juro.2009.02.105. Epub 2009 May 17. J Urol. 2009. PMID: 19447430 Free PMC article. Clinical Trial.

2

Taxanes: an overview of the pharmacokinetics and pharmacodynamics.

Vaishampayan U, Parchment RE, Jasti BR, Hussain M. Vaishampayan U, et al. Urology. 1999 Dec;54(6A Suppl):22-9. doi: 10.1016/s0090-4295(99)00451-3. Urology. 1999. PMID: 10606281 Review.

3

Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.

Vaishampayan U, Glode M, Du W, Kraft A, Hudes G, Wright J, Hussain M. Vaishampayan U, et al. Clin Cancer Res. 2000 Nov;6(11):4205-8. Clin Cancer Res. 2000. PMID: 11106233 Clinical Trial.

4

Adjuvant chemo-/hormonal therapy trials for locally advanced prostate cancer.

Vaishampayan U, Hussain M. Vaishampayan U, et al. Curr Oncol Rep. 2000 Sep;2(5):402-8. doi: 10.1007/s11912-000-0059-z. Curr Oncol Rep. 2000. PMID: 11122871 Review.

5

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

Hussain M, Vaishampayan U, Du W, Redman B, Smith DC. Hussain M, et al. J Clin Oncol. 2001 May 1;19(9):2527-33. doi: 10.1200/JCO.2001.19.9.2527. J Clin Oncol. 2001. PMID: 11331332

6

Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.

Vaishampayan U, Flaherty L, Du W, Hussain M. Vaishampayan U, et al. Cancer. 2001 Aug 1;92(3):519-23. doi: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-#. Cancer. 2001. PMID: 11505395 Clinical Trial.

7

The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st century.

Vaishampayan U, Hussain M. Vaishampayan U, et al. Crit Rev Oncol Hematol. 2002 May;42(2):179-88. doi: 10.1016/s1040-8428(01)00187-1. Crit Rev Oncol Hematol. 2002. PMID: 12007976 Review.

8

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.

Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF. Vaishampayan UN, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):675-9. doi: 10.1016/s0360-3016(02)02772-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12062611

9

Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.

Vaishampayan U, Abrams J, Darrah D, Jones V, Mitchell MS. Vaishampayan U, et al. Clin Cancer Res. 2002 Dec;8(12):3696-701. Clin Cancer Res. 2002. PMID: 12473578 Review.

10

An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.

Vaishampayan U, Fontana J, Du W, Hussain M. Vaishampayan U, et al. Urology. 2002 Dec;60(6):1050-4. doi: 10.1016/s0090-4295(02)01990-8. Urology. 2002. PMID: 12475668 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters